Thomas Luke's Insider Trades & SAST Disclosures
Thomas Luke's most recent trade in SAB Biotherapeutics Inc was a trade of 139,585 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Oct. 19, 2021.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Thomas Luke.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
|
SAB Biotherapeutics Inc
|
Thomas Luke | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Oct 2021 | 139,585 | 139,585 | - | - | Employee Stock Option (right to buy) | |
|
SAB Biotherapeutics Inc
|
Thomas Luke | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Oct 2021 | 61,092 | 61,092 | - | - | Earnout Rights (Restricted Stock Units) | |
|
SAB Biotherapeutics Inc
|
Thomas Luke | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Oct 2021 | 11,632 | 11,632 | - | - | Employee Stock Option (right to buy) | |
|
SAB Biotherapeutics Inc
|
Thomas Luke | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Oct 2021 | 5,428 | 5,428 | - | - | Common Stock | |
|
SAB Biotherapeutics Inc
|
Thomas Luke | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Oct 2021 | 2,193 | 2,193 | - | - | Earnout Rights (Common Stock) | |
|
SAB Biotherapeutics Inc
|
Thomas Luke | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 10.10 per share. | 19 Oct 2021 | 990 | 990 | - | 10.1 | 9,999 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges